{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:27:05Z","timestamp":1792218425488,"version":"4.4.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T00:00:00Z","timestamp":1684800000000},"content-version":"vor","delay-in-days":417,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jtct.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:22:24Z","timestamp":1648534944000},"page":"179-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["VOD\/SOS and Alkylating Agents in the Hematopoietic Stem Cell Transplant Setting: New Insights and Further Questions"],"prefix":"10.1016","volume":"28","author":[{"given":"Alan L.","family":"Myers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"29","key":"10.1016\/j.jtct.2022.03.001_bib0001","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.3748\/wjg.v13.i29.3918","article-title":"Veno occlusive disease: update on clinical management","volume":"13","author":"Senzolo","year":"2007","journal-title":"World J Gastroenterol"},{"issue":"9","key":"10.1016\/j.jtct.2022.03.001_bib0002","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1080\/17425255.2017.1360277","article-title":"Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review","volume":"13","author":"Myers","year":"2017","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"10.1016\/j.jtct.2022.03.001_bib0003","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk Factors for Development of and Progression of Hepatic Veno-Occlusive Disease\/Sinusoidal Obstruction Syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2022.03.001_bib0004","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12887-020-02028-6","article-title":"Busulfan systemic exposure and its relationship with efficacy and safety in hematopoietic stem cell transplantation in children: a meta-analysis","volume":"20","author":"Feng","year":"2020","journal-title":"BMC Pediatr"},{"issue":"3","key":"10.1016\/j.jtct.2022.03.001_bib0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41409-018-0281-7","article-title":"Maximal concentration of intravenous busulfan as a determinant of veno-occlusive disease: a pharmacokinetic-pharmacodynamic analysis in 293 hematopoietic stem cell transplanted children","volume":"54","author":"Philippe","year":"2019","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2022.03.001_bib0006","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbmt.2008.11.022","article-title":"Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation","volume":"15","author":"Bartelink","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2022.03.001_bib0007","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pbc.22959","article-title":"Weight-based strategy of dose administration in children using intravenous busulfan: clinical and pharmacokinetic results","volume":"58","author":"Michel","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"10.1016\/j.jtct.2022.03.001_bib0008","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.bbmt.2018.06.013","article-title":"Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant","volume":"24","author":"Strouse","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.03.001_bib0009","series-title":"Association between the magnitude of intravenous busulfan exposure and development of hepatic veno-occlusive disease in children and young adults undergoing myeloablative allogeneic hematopoietic cell transplantation","author":"Bognar","year":"2022"},{"key":"10.1016\/j.jtct.2022.03.001_bib0010","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev.bi.52.070183.003431","article-title":"Glutathione","volume":"52","author":"Meister","year":"1983","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"10.1016\/j.jtct.2022.03.001_bib0011","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0003-9861(88)90592-9","article-title":"The spontaneous and enzymatic reaction of N-acetyl-p-benzoquinonimine with glutathione: a stopped-flow kinetic study","volume":"264","author":"Coles","year":"1988","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"10.1016\/j.jtct.2022.03.001_bib0012","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0090-9556(25)07498-7","article-title":"Busulfan conjugation by glutathione S-transferases alpha, mu, and pi","volume":"24","author":"Czerwinski","year":"1996","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.jtct.2022.03.001_bib0013","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/tx950143c","article-title":"Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases","volume":"9","author":"Dirven","year":"1996","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"10.1016\/j.jtct.2022.03.001_bib0014","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000028359","article-title":"Role of oxidative stress and glutathione in busulfan toxicity in cultured murine hepatocytes","volume":"60","author":"DeLeve","year":"2000","journal-title":"Pharmacology"},{"issue":"16","key":"10.1016\/j.jtct.2022.03.001_bib0015","first-page":"3678","article-title":"Busulfan-glutathione conjugation catalyzed by human liver cytosolic glutathione S-transferases","volume":"56","author":"Gibbs","year":"1996","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.jtct.2022.03.001_bib0016","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbrc.2020.09.038","article-title":"Electrophilic reactivity of the Busulfan metabolite, EdAG, towards cellular thiols and inhibition of human thioredoxin-1","volume":"533","author":"Hoang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"10.1016\/j.jtct.2022.03.001_bib0017","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/jpet.108.142208","article-title":"Dehydroalanine analog of glutathione: an electrophilic busulfan metabolite that binds to human glutathione S-transferase A1-1","volume":"327","author":"Younis","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jtct.2022.03.001_bib0018","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.abb.2015.08.005","article-title":"The busulfan metabolite EdAG irreversibly glutathionylates glutaredoxins","volume":"583","author":"Scian","year":"2015","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10.1016\/j.jtct.2022.03.001_bib0019","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2022.03.001_bib0020","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/bcpt.13185","article-title":"Effect of glutathione S-transferase genetic polymorphisms on busulfan pharmacokinetics and veno-occlusive disease in hematopoietic stem cell transplantation: A meta-analysis","volume":"124","author":"Kim","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722001233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722001233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:02:21Z","timestamp":1763002941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722001233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2666636722001233"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.03.001","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VOD\/SOS and Alkylating Agents in the Hematopoietic Stem Cell Transplant Setting: New Insights and Further Questions","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}